The specificity of T lymphocyte activation is determined by engagement of the T cell receptor (TCR) by peptide/major histocompatibility complexes expressed on the antigen-presenting cell (APC). Lacking costimulation by accessory molecules on the APC, T cell proliferation does not occur and unresponsiveness to subsequent antigenic stimulus is induced. The B7/BB1 receptor on APCs binds CD28 and CTLA-4 on T cells, and provides a costimulus for T cell proliferation. Here, we show that prolonged, specific T cell hyporesponsiveness to antigenic restimulation is achieved by blocking the interaction between CD28 and B7/BB1 in human mixed leukocyte culture (MLC). Secondary T cell proliferative responses to specific alloantigen were inhibited by addition to the primary culture of monovalent Fab fragments of anti-CD28 monoclonal antibody (mAb) 9.3, which block interaction of CD28 with B7/BB1 without activating T cells. Hypo-responsiveness was also induced in MLC by CTLA4Ig, a chimeric immunoglobulin fusion protein incorporating the extracellular domain of CTLA-4 with high binding avidity for B7/BB1. Cells previously primed could also be made hyporesponsive, if exposed to alloantigen in the presence of CTLA4Ig. Maximal hyporesponsiveness was achieved in MLC after 2 d of incubation with CTLA4Ig, and was maintained for at least 27 d after removal of CTLA4Ig. Accumulation of interleukin 2 (IL-2) and interferon gamma but not IL-4 mRNA was blocked by CTLA4Ig in T cells stimulated by alloantigen. Antigen-specific responses could be restored by addition of exogenous IL-2 at the time of the secondary stimulation. Addition to primary cultures of the intact bivalent anti-CD28 mAb 9.3, or B7/BB1+ transfected CHO cells or exogenous IL-2, abrogated induction of hyporesponsiveness by CTLA4Ig. These data indicate that interaction of CD28 with B7/BB1 during TCR engagement with antigen is required to maintain T cell competence and that blocking such interaction can result in a state of T cell hyporesponsiveness.
Skip Nav Destination
Article navigation
1 January 1993
Article|
January 01 1993
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
P Tan,
P Tan
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Search for other works by this author on:
C Anasetti,
C Anasetti
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Search for other works by this author on:
J A Hansen,
J A Hansen
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Search for other works by this author on:
J Melrose,
J Melrose
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Search for other works by this author on:
M Brunvand,
M Brunvand
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Search for other works by this author on:
J Bradshaw,
J Bradshaw
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Search for other works by this author on:
J A Ledbetter,
J A Ledbetter
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Search for other works by this author on:
P S Linsley
P S Linsley
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Search for other works by this author on:
P Tan
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
C Anasetti
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
J A Hansen
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
J Melrose
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
M Brunvand
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
J Bradshaw
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
J A Ledbetter
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
P S Linsley
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1993) 177 (1): 165–173.
Citation
P Tan, C Anasetti, J A Hansen, J Melrose, M Brunvand, J Bradshaw, J A Ledbetter, P S Linsley; Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.. J Exp Med 1 January 1993; 177 (1): 165–173. doi: https://doi.org/10.1084/jem.177.1.165
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement